Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
Condition(s):Myelofibrosis (MF)Last Updated:September 29, 2023Active, not recruiting